
Loading, please wait...

Loading, please wait...

Chirality remains a fundamental property in modern pharmacology, as mirror-image enantiomers often exhibit vastly different biological activities. Consequently, achieving precise chiral drug enantioseparation is a critical technical hurdle for the pharmaceutical industry. This recent review chronicles the development of interfacial super-assembled hetero-structured chiral nanochannel membranes, representing a transformative shift in separation science.
Researchers are now constructing hierarchical membranes from zero- to three-dimensional building blocks. By employing a versatile toolbox of interfacial assembly strategies like phase inversion and electrospinning, they can create complex architectures. These design principles, such as pore-in-pore and multichannel configurations, are specifically engineered to break the conventional permeability-selectivity trade-off. Furthermore, these structures provide the high surface area necessary for sensitive molecular recognition.
The core of these membranes lies in their advanced transport mechanisms. Traditional diffusion-selective and adsorption-selective pathways are now being supplemented by recently proposed couple-accelerated-selective transport. This mechanism significantly enhances the speed and accuracy of separation. Representative material systems, including metal-organic frameworks (MOFs) and molecularly imprinted polymers (MIPs), have shown exceptional promise in mimicking biological channels for high-throughput applications.
While the potential is vast, several persistent challenges remain. Scalability and long-term stability under industrial conditions are primary concerns for developers. However, the integration of artificial intelligence (AI)-assisted design is set to optimize these membranes rapidly. Moreover, bioinspired dynamic membranes offer a forward-looking perspective on creating responsive technologies that could adapt to different enantiomeric mixtures in real-time.
Enantioseparation is vital because one enantiomer of a drug may provide the therapeutic benefit while the other could be inactive or even toxic. Ensuring high enantiomeric purity is essential for patient safety and meeting stringent regulatory guidelines from agencies like the FDA.
Nanochannel membranes provide specialized pathways that can distinguish between molecules based on their spatial arrangement. These membranes utilize hierarchical structures to allow high flow rates (permeability) without sacrificing the accuracy of the separation (selectivity).
The future involves using AI to design more efficient membrane structures and developing bioinspired systems that can change their properties dynamically. These advancements will help overcome current issues with membrane stability and manufacturing scale-up.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical or pharmaceutical advice. The technologies described are in research and development stages. Refer to the latest local and national guidelines for clinical practice and pharmaceutical manufacturing standards.
References
Huang Y et al. Interfacial Super-Assembled Hetero-Structured Chiral Nanochannels for Enantioseparation Applications. Adv Mater. 2026 Apr 10. doi: 10.1002/adma.202523689. PMID: 41960631.
Auerbach M. Chiral Separation and Enantiomeric Analysis: Critical Importance in Pharmaceutical Development. American Pharmaceutical Review. 2025 Jun 01.
Recent Advances in Enantiorecognition and Enantioseparation Techniques of Chiral Molecules in the Pharmaceutical Field. PubMed. 2025 Feb 15. PMID: 38356124.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A review of interfacial super-assembled hetero-structured nanochannels for efficient enantioseparation, highlighting new mechanisms and AI-assisted design....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today